The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation. 2011

Lysann Palkowitsch, and Uta Marienfeld, and Cornelia Brunner, and Andrea Eitelhuber, and Daniel Krappmann, and Ralf B Marienfeld
Institute of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany.

T cell receptor (TCR) ligation induces increased diacylglycerol and Ca(2+) levels in T cells, and both secondary messengers are crucial for TCR-induced nuclear factor of activated T cells (NF-AT) and NF-κB signaling pathways. One prominent calcium-dependent enzyme involved in the regulation of NF-AT and NF-κB signaling pathways is the protein phosphatase calcineurin. However, in contrast to NF-AT, which is directly dephosphorylated by calcineurin, the molecular basis of the calcium-calcineurin dependence of the TCR-induced NF-κB activity remains largely unknown. Here, we demonstrate that calcineurin regulates TCR-induced NF-κB activity by controlling the formation of a protein complex composed of Carma1, Bcl10, and Malt1 (CBM complex). For instance, increased calcium levels induced by ionomycin or thapsigargin augmented the phorbol 12-myristate 13-acetate-induced formation of the CBM complex and activation of NF-κB, whereas removal of calcium by the calcium chelator EGTA-acetoxymethyl ester (AM) attenuated both processes. Furthermore, inhibition of the calcium-dependent phosphatase calcineurin with the immunosuppressive agent cyclosporin A (CsA) or FK506 as well as siRNA-mediated knockdown of calcineurin A strongly affected the PMA + ionomycin- or anti-CD3 + CD28-induced CBM complex assembly. Mechanistically, the positive effect of calcineurin on the CBM complex formation seems to be linked to a dephosphorylation of Bcl10. For instance, Bcl10 was found to be hyperphosphorylated in Jurkat T cells upon treatment with CsA or EGTA-AM, and calcineurin dephosphorylated Bcl10 in vivo and in vitro. Furthermore, we show here that calcineurin A interacts with the CBM complex. In summary, the evidence provided here argues for a previously unanticipated role of calcineurin in CBM complex formation as a molecular basis of the inhibitory function of CsA or FK506 on TCR-induced NF-κB activity.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004533 Egtazic Acid A chelating agent relatively more specific for calcium and less toxic than EDETIC ACID. EGTA,Ethylene Glycol Tetraacetic Acid,EGATA,Egtazic Acid Disodium Salt,Egtazic Acid Potassium Salt,Egtazic Acid Sodium Salt,Ethylene Glycol Bis(2-aminoethyl ether)tetraacetic Acid,Ethylenebis(oxyethylenenitrile)tetraacetic Acid,GEDTA,Glycoletherdiamine-N,N,N',N'-tetraacetic Acid,Magnesium-EGTA,Tetrasodium EGTA,Acid, Egtazic,EGTA, Tetrasodium,Magnesium EGTA
D006162 Guanylate Cyclase An enzyme that catalyzes the conversion of GTP to 3',5'-cyclic GMP and pyrophosphate. It also acts on ITP and dGTP. (From Enzyme Nomenclature, 1992) EC 4.6.1.2. Guanyl Cyclase,Deoxyguanylate Cyclase,Guanylyl Cyclase,Inosinate Cyclase,Cyclase, Deoxyguanylate,Cyclase, Guanyl,Cyclase, Guanylate,Cyclase, Guanylyl,Cyclase, Inosinate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074018 B-Cell CLL-Lymphoma 10 Protein A signal transducing adaptor protein that contains an N-terminal CARD DOMAIN and functions in the ADAPTIVE IMMUNE RESPONSE. It promotes PRO-CASPASE-9 maturation and APOPTOSIS, activation of NF-KAPPA B, and is a substrate for MALT1 PARACASPASE. B-Cell Lymphoma-Leukemia 10 Protein,Bcl-10 Protein,Bcl10 Protein,B Cell CLL Lymphoma 10 Protein,B Cell Lymphoma Leukemia 10 Protein,Bcl 10 Protein
D000074884 Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein A caspase-like cysteine endopeptidase that also exhibits ubiquitin ligase activity. It contains an N-terminal DEATH DOMAIN, two IMMUNOGLOBULIN-LIKE DOMAINS, and localizes to the perinuclear region of MONOCYTES, where it functions in activation of NF-KAPPA B; it also binds to and activates TRAF6. Chromosomal translocations involving the MALT1 and BIRC2 genes are associated with MALT LYMPHOMA, and mutations in the MALT1 gene are associated with Type 12 IMMUNODEFICIENCY SYNDROMES. MALT-1 Protein,MALT1 Paracaspase,MALT1 Protein,Paracaspase,MALT 1 Protein,Mucosa Associated Lymphoid Tissue Lymphoma Translocation 1 Protein,Paracaspase, MALT1

Related Publications

Lysann Palkowitsch, and Uta Marienfeld, and Cornelia Brunner, and Andrea Eitelhuber, and Daniel Krappmann, and Ralf B Marienfeld
July 2014, Cell communication and signaling : CCS,
Lysann Palkowitsch, and Uta Marienfeld, and Cornelia Brunner, and Andrea Eitelhuber, and Daniel Krappmann, and Ralf B Marienfeld
August 2003, Trends in immunology,
Lysann Palkowitsch, and Uta Marienfeld, and Cornelia Brunner, and Andrea Eitelhuber, and Daniel Krappmann, and Ralf B Marienfeld
June 2009, EMBO reports,
Lysann Palkowitsch, and Uta Marienfeld, and Cornelia Brunner, and Andrea Eitelhuber, and Daniel Krappmann, and Ralf B Marienfeld
September 2010, Cold Spring Harbor perspectives in biology,
Lysann Palkowitsch, and Uta Marienfeld, and Cornelia Brunner, and Andrea Eitelhuber, and Daniel Krappmann, and Ralf B Marienfeld
April 2004, The Journal of biological chemistry,
Lysann Palkowitsch, and Uta Marienfeld, and Cornelia Brunner, and Andrea Eitelhuber, and Daniel Krappmann, and Ralf B Marienfeld
June 2014, Science signaling,
Lysann Palkowitsch, and Uta Marienfeld, and Cornelia Brunner, and Andrea Eitelhuber, and Daniel Krappmann, and Ralf B Marienfeld
December 2007, The Journal of experimental medicine,
Lysann Palkowitsch, and Uta Marienfeld, and Cornelia Brunner, and Andrea Eitelhuber, and Daniel Krappmann, and Ralf B Marienfeld
September 2008, Blood,
Lysann Palkowitsch, and Uta Marienfeld, and Cornelia Brunner, and Andrea Eitelhuber, and Daniel Krappmann, and Ralf B Marienfeld
November 2014, European journal of medical research,
Lysann Palkowitsch, and Uta Marienfeld, and Cornelia Brunner, and Andrea Eitelhuber, and Daniel Krappmann, and Ralf B Marienfeld
December 2005, Immunity,
Copied contents to your clipboard!